Paul Van Gompel

2.5k total citations · 1 hit paper
26 papers, 2.1k citations indexed

About

Paul Van Gompel is a scholar working on Molecular Biology, Cellular and Molecular Neuroscience and Sensory Systems. According to data from OpenAlex, Paul Van Gompel has authored 26 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 19 papers in Cellular and Molecular Neuroscience and 2 papers in Sensory Systems. Recurrent topics in Paul Van Gompel's work include Receptor Mechanisms and Signaling (16 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroscience and Neuropharmacology Research (5 papers). Paul Van Gompel is often cited by papers focused on Receptor Mechanisms and Signaling (16 papers), Neurotransmitter Receptor Influence on Behavior (13 papers) and Neuroscience and Neuropharmacology Research (5 papers). Paul Van Gompel collaborates with scholars based in Belgium, Sweden and Netherlands. Paul Van Gompel's co-authors include W Gommeren, J.E. Leysen, Anne Lesage, Alain Schotte, Walter Luyten, Paul Janssen, J. Wynants, Josée E. Leysen, Pierre M. Laduron and P.F.M. Janssen and has published in prestigious journals such as Journal of Biological Chemistry, Neuroscience and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Paul Van Gompel

26 papers receiving 2.0k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding

1996 971 citations Alain Schotte, Paul Janssen et al. Psychopharmacology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Paul Van Gompel Belgium	15	1.3k	895	616	214	178	26	2.1k
R J Baldessarini United States	28	946 0.7×	746 0.8×	566 0.9×	229 1.1×	246 1.4×	62	2.1k
Kazufumi Akiyama Japan	26	1.5k 1.1×	1.0k 1.1×	348 0.6×	151 0.7×	200 1.1×	94	2.1k
Y. Claustre France	22	1.1k 0.8×	682 0.8×	322 0.5×	217 1.0×	150 0.8×	32	1.7k
Saburo Otsuki Japan	29	1.7k 1.3×	1.1k 1.2×	856 1.4×	238 1.1×	271 1.5×	150	3.0k
David G. Grahame‐Smith United Kingdom	23	1.3k 1.0×	779 0.9×	279 0.5×	213 1.0×	230 1.3×	40	2.1k
David J. Brunswick United States	27	857 0.7×	607 0.7×	424 0.7×	418 2.0×	158 0.9×	70	1.9k
T. Lee Canada	5	1.0k 0.8×	703 0.8×	554 0.9×	122 0.6×	99 0.6×	5	1.6k
M. Chau-Wong Canada	11	1.4k 1.1×	1.1k 1.2×	722 1.2×	198 0.9×	145 0.8×	13	2.2k
J E Leysen Belgium	13	1.2k 0.9×	920 1.0×	282 0.5×	160 0.7×	208 1.2×	20	1.8k
Alain Schotte Belgium	23	1.8k 1.4×	1.3k 1.4×	1.3k 2.0×	308 1.4×	177 1.0×	39	3.1k

Countries citing papers authored by Paul Van Gompel

Since Specialization

Citations

This map shows the geographic impact of Paul Van Gompel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Paul Van Gompel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Paul Van Gompel more than expected).

Fields of papers citing papers by Paul Van Gompel

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Paul Van Gompel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Paul Van Gompel. The network helps show where Paul Van Gompel may publish in the future.

Co-authorship network of co-authors of Paul Van Gompel

This figure shows the co-authorship network connecting the top 25 collaborators of Paul Van Gompel. A scholar is included among the top collaborators of Paul Van Gompel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Paul Van Gompel. Paul Van Gompel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Gompel, Paul Van, et al.. (2002). Differences in Signal Transduction of Two 5-HT4Receptor Splice Variants: Compound Specificity and Dual Coupling with Gαs- and Gαi/o-Proteins. Molecular Pharmacology. 61(1). 85–96. 91 indexed citations

Lavreysen, Hilde, Emmanuel Le Poul, Paul Van Gompel, et al.. (2002). Supersensitivity of Human Metabotropic Glutamate 1a Receptor Signaling in L929sA Cells. Molecular Pharmacology. 61(5). 1244–1254. 10 indexed citations

Masure, Stefan, Miroslav Cik, Christopher A. Nosrat, et al.. (2000). Mammalian GFRα-4, a Divergent Member of the GFRα Family of Coreceptors for Glial Cell Line-derived Neurotrophic Factor Family Ligands, Is a Receptor for the Neurotrophic Factor Persephin. Journal of Biological Chemistry. 275(50). 39427–39434. 46 indexed citations

Cik, Miroslav, Stefan Masure, Anne Lesage, et al.. (2000). Binding of GDNF and Neurturin to Human GDNF Family Receptor α 1 and 2. Journal of Biological Chemistry. 275(36). 27505–27512. 55 indexed citations

Lesage, Anne, Ria Wouters, Paul Van Gompel, et al.. (1998). Agonistic properties of alniditan, sumatriptan and dihydroergotamine on human 5‐HT_1B and 5‐HT_1D receptors expressed in various mammalian cell lines. British Journal of Pharmacology. 123(8). 1655–1665. 31 indexed citations

Schotte, Alain, Paul Janssen, W Gommeren, et al.. (1996). Risperidone compared with new and reference antipsychotic drugs: in vitro and in vivo receptor binding. Psychopharmacology. 124(1-2). 57–73. 971 indexed citations breakdown →

Leysen, J.E., W Gommeren, Lieve Heylen, et al.. (1996). Alniditan, a new 5-hydroxytryptamine1D agonist and migraine-abortive agent: ligand-binding properties of human 5-hydroxytryptamine1D alpha, human 5-hydroxytryptamine1D beta, and calf 5-hydroxytryptamine1D receptors investigated with [3H]5-hydroxytryptamine and [3H]alniditan.. Molecular Pharmacology. 50(6). 1567–1580. 78 indexed citations

Pauwels, Petrus J., Paul Van Gompel, & Josée E. Leysen. (1993). Activity of serotonin (5-HT) receptor agonists, partial agonists and antagonists at cloned human 5-HT1a receptors that are negatively coupled to adenylate cyclase in permanently transfected hela cells. Biochemical Pharmacology. 45(2). 375–383. 76 indexed citations

Pauwels, Petrus J., Paul Van Gompel, & Josée E. Leysen. (1990). Rapid desensitization and resensitization of 5-HT2 receptor mediated phosphatidyl inositol hydrolysis by serotonin agonists in quiescent calf aortic smooth muscle cells. Life Sciences. 47(22). 2009–2019. 32 indexed citations

10.

Leysen, Josée E., W Gommeren, & Paul Van Gompel. (1988). The Dissociation Rate of Unlabelled Drugs from Receptor Sites: A Poorly Investigated, Yet Important Aspect in Receptor Research. Studies on the Serotonin-S₂Receptor. Journal of Receptor Research. 8(1-4). 547–559. 6 indexed citations

11.

Pauwels, Petrus J., Paul Van Gompel, Didier de Chaffoy de Courcelles, & Josée E. Leysen. (1988). Agonist-induced desensitization of 5-HT2 receptors on cultured calf aortic smooth muscle cells. Neurochemistry International. 13(3). 409–414. 7 indexed citations

12.

Leysen, Josée E., Paul Van Gompel, & W Gommeren. (1988). Distinction Between Adrenergic and Serotonergic Receptor Subtypes. Journal of Cardiovascular Pharmacology. 11(Sup 1). S78–S87. 4 indexed citations

13.

Leysen, J.E., et al.. (1988). Identification of nonserotonergic [3H]ketanserin binding sites associated with nerve terminals in rat brain and with platelets; relation with release of biogenic amine metabolites induced by ketanserin- and tetrabenazine-like drugs.. Journal of Pharmacology and Experimental Therapeutics. 244(1). 310–321. 55 indexed citations

14.

Leysen, J.E., W Gommeren, P.F.M. Janssen, Paul Van Gompel, & Patricia A. Janssen. (1988). Receptor Interactions of Dopamine and Serotonin Antagonists: Binding In Vitro and In Vivo and Receptor Regulation. PubMed. 5. 12–26. 12 indexed citations

15.

Leysen, J.E., et al.. (1987). Non-serotonergic [3H]ketanserin binding sites in striatal membranes are associated with a dopac release system on dopaminergic nerve endings. European Journal of Pharmacology. 134(3). 373–375. 32 indexed citations

16.

Leysen, J.E., et al.. (1987). Opposite Regulation of Serotonin-S₂and Dopamine-D₂Receptors in Rat Brain Following Chronic Receptor Blockade. Journal of Receptor Research. 7(1-4). 223–239. 19 indexed citations

17.

Leysen, J.E., Paul Van Gompel, W Gommeren, R. Woestenborghs, & Paul A. J. Janssen. (1986). Down regulation of serotonin-S2 receptor sites in rat brain by chronic treatment with the serotonin-S2 antagonists: ritanserin and setoperone. Psychopharmacology. 88(4). 434–444. 129 indexed citations

18.

Leysen, J.E., W Gommeren, Paul Van Gompel, et al.. (1985). Receptor-binding properties in vitro and in vivo of ritanserin: A very potent and long acting serotonin-S2 antagonist.. Molecular Pharmacology. 27(6). 600–611. 409 indexed citations

19.

Leysen, Josée E. & Paul Van Gompel. (1982). Effects of proteolytic enzymes and monovalent ions demonstrate proteasesensitive and protease-insensitive stereospecific binding sites on dopaminergic receptors in rat striatum. Biochemical Pharmacology. 31(7). 1343–1355. 3 indexed citations

20.

Laduron, Pierre M., et al.. (1976). Tissue fractionation and catecholamines —IV. Adenosine triphosphatase in chromaffin granules: A distribution artefact. Neuroscience. 1(3). 219–226. 11 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact